Found: 8
Select item for more details and to access through your institution.
Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes: The ORCA-V1 Randomized Clinical Trial.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 8, p. 922, doi. 10.1001/jamainternmed.2024.1313
- By:
- Publication type:
- Article
In Vivo Biological Effects of Recombinant Soluble lnterleukin-4 Receptor.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1994, v. 206, n. 3, p. 233, doi. 10.3181/00379727-206-43750
- By:
- Publication type:
- Article
Cytisinicline for Smoking Cessation: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 2, p. 152, doi. 10.1001/jama.2023.10042
- By:
- Publication type:
- Article
A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability, and Safety of Cytisinicline in Adult Smokers.
- Published in:
- Nicotine & Tobacco Research, 2023, v. 25, n. 4, p. 814, doi. 10.1093/ntr/ntac233
- By:
- Publication type:
- Article
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Book reviews.
- Published in:
- 1996
- By:
- Publication type:
- Book Review
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small‐Cell Lung Cancer: The SPRUCE Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1409, doi. 10.1634/theoncologist.2018-0518
- By:
- Publication type:
- Article